As part of a clinical trial investigating the CYP3A activity in palliative cancer patients, this analysis is dealing with the metabolism of fentanyl in a special population under real-life clinical conditions in order to increase knowledge about the influence of CYP3A. The gene discussed is CYP3A4; the disease is cancer.